Immunostimulation By Chemically Modified Rna

Patent No. EP2216028 (titled "Immunostimulation By Chemically Modified Rna") was filed by Curevac on Jul 3, 2003. The application was issued on Dec 6, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ETHERNA IMMUNOTHERAPIESSep 6, 2018LC PATENTS
STRAWMANSep 5, 2018VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
SCHNAPPAUFSep 4, 2018-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2216028

CUREVAC
Application Number
EP10005375A
Filing Date
Jul 3, 2003
Status
Revoked
May 29, 2020
Publication Date
Dec 6, 2017